Market Cap 18.01M
Revenue (ttm) 10,000.00
Net Income (ttm) -23.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -233,600.01%
Debt to Equity Ratio 0.00
Volume 38,300
Avg Vol 43,518
Day's Range N/A - N/A
Shares Out 11.70M
Stochastic %K 10%
Beta 0.55
Analysts Hold
Price Target $1.00

Company Profile

Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 659 2802
Address:
PO Box 30, Winchester, United States
KhalidsCapital
KhalidsCapital Jul. 20 at 3:11 AM
RSLS is a low-float biotech just waiting for the spark. It’s got structure, a merger catalyst, and no toxic overhead all under $1. Once the move starts, it could halt its way up the chart. Perfect storm forming quietly…. $SABS $SYBX $ACXP $SEEL
0 · Reply
AsymmetricVentures
AsymmetricVentures Jul. 18 at 5:51 PM
Cable Car Cap controlled 9+% of $MEIP as of their last 13F. With that Digital Treasury deal out of the way ... they can focus on $SYBX, where they own 4.5+% per their last 13F
0 · Reply
Chrissytina
Chrissytina Jul. 16 at 3:02 PM
$SYBX 138,124 volume 😳 that’s a lot for this company!
0 · Reply
jaydilks
jaydilks Jul. 16 at 2:25 PM
$DNA Old news release might have validity why $17 Mill Market Cap, $SYBX stock is suddenly off life support. My guess would be GOUT Therapeutic. I’d own DNA over SYBX because of the leverage DNA has in ownership and IP. (Speculation Alert). Take it with a grain of Salt. https://www.prnewswire.com/news-releases/synlogic-announces-synthetic-biotic-for-gout-developed-in-partnership-with-ginkgo-bioworks-301603915.html
2 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 4:06 PM
$SYBX DUE TO THIS!*
1 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 3:56 PM
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 3:56 PM
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 10:31 AM
$ALTO working on something for u some what soon $SYBX need to change foew things on sybx side note timer issue
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 9 at 10:16 PM
$SYBX $SBFM making changes for u both
1 · Reply
Love_To_Learn
Love_To_Learn Jul. 9 at 4:18 PM
$SYBX will need to do something with u soon have sidelined u for quite a bit it tight for now
0 · Reply
Latest News on SYBX
Synlogic Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 4:35 PM EST - 9 months ago

Synlogic Reports Third Quarter 2024 Financial Results


Synlogic Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Synlogic Reports Second Quarter 2024 Financial Results


Synlogic Reports First Quarter 2024 Financial Results

May 14, 2024, 7:00 AM EDT - 1 year ago

Synlogic Reports First Quarter 2024 Financial Results


Synlogic Adopts Limited Duration Stockholders Rights Plan

Feb 20, 2024, 12:15 PM EST - 1 year ago

Synlogic Adopts Limited Duration Stockholders Rights Plan


Synlogic Provides Corporate Update and Outlook for 2024

Jan 4, 2024, 7:00 AM EST - 1 year ago

Synlogic Provides Corporate Update and Outlook for 2024


Synlogic Announces Contract with the Air Force Research Lab

Dec 27, 2023, 7:00 AM EST - 1 year ago

Synlogic Announces Contract with the Air Force Research Lab


Synlogic Announces Reverse Stock Split

Sep 27, 2023, 12:30 PM EDT - 2 years ago

Synlogic Announces Reverse Stock Split


Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100

Sep 19, 2023, 11:00 AM EDT - 2 years ago

Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100


Synlogic Provides Corporate Update and Outlook for 2023

Jan 5, 2023, 6:58 AM EST - 2 years ago

Synlogic Provides Corporate Update and Outlook for 2023


KhalidsCapital
KhalidsCapital Jul. 20 at 3:11 AM
RSLS is a low-float biotech just waiting for the spark. It’s got structure, a merger catalyst, and no toxic overhead all under $1. Once the move starts, it could halt its way up the chart. Perfect storm forming quietly…. $SABS $SYBX $ACXP $SEEL
0 · Reply
AsymmetricVentures
AsymmetricVentures Jul. 18 at 5:51 PM
Cable Car Cap controlled 9+% of $MEIP as of their last 13F. With that Digital Treasury deal out of the way ... they can focus on $SYBX, where they own 4.5+% per their last 13F
0 · Reply
Chrissytina
Chrissytina Jul. 16 at 3:02 PM
$SYBX 138,124 volume 😳 that’s a lot for this company!
0 · Reply
jaydilks
jaydilks Jul. 16 at 2:25 PM
$DNA Old news release might have validity why $17 Mill Market Cap, $SYBX stock is suddenly off life support. My guess would be GOUT Therapeutic. I’d own DNA over SYBX because of the leverage DNA has in ownership and IP. (Speculation Alert). Take it with a grain of Salt. https://www.prnewswire.com/news-releases/synlogic-announces-synthetic-biotic-for-gout-developed-in-partnership-with-ginkgo-bioworks-301603915.html
2 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 4:06 PM
$SYBX DUE TO THIS!*
1 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 3:56 PM
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 3:56 PM
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 15 at 10:31 AM
$ALTO working on something for u some what soon $SYBX need to change foew things on sybx side note timer issue
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 9 at 10:16 PM
$SYBX $SBFM making changes for u both
1 · Reply
Love_To_Learn
Love_To_Learn Jul. 9 at 4:18 PM
$SYBX will need to do something with u soon have sidelined u for quite a bit it tight for now
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 25 at 10:27 AM
$SYBX u have an update pending timing is not good in general for market dynamics may need to delay temp on this
0 · Reply
Love_To_Learn
Love_To_Learn Apr. 30 at 10:50 AM
$ONFO $SYBX need u 2 rest of week nect bunch of trading days overlap with beloved situation and iotr too many to post
0 · Reply
PenkeTrading
PenkeTrading Apr. 5 at 5:03 PM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Synlogic Inc. Is that bullish or bearish? $SYBX #Synlogic #RsiOversold #NASDAQ
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 27 at 12:23 PM
$SYBX Tough break for SYBX after dropping PKU trial. Biotech's brutal - one miss can tank everything. Watching closely for strategic moves. Might be a value play if they find a buyer. Lean team, cash runway looking thin. Synthetic Biotics platform still intriguing. excellent article: https://beyondspx.com/article/synlogic-inc-sybx-navigating-the-complexities-of-the-biotech-landscape
0 · Reply
Kaltycoon
Kaltycoon Mar. 14 at 12:42 PM
$SYBX low float ticker? Any life detected here?
0 · Reply
MoCoHai
MoCoHai Feb. 12 at 7:42 PM
$SYBX das hier ist ein no Brainer pick, korrekt? Läuft nicht so, wa?!?
0 · Reply
Brentmcneil
Brentmcneil Jan. 6 at 3:34 PM
$SYBX bullish
0 · Reply
Mrvandepol
Mrvandepol Dec. 11 at 8:46 PM
0 · Reply
PharmaExpert
PharmaExpert Dec. 11 at 5:49 PM
$AKBA, $CADL, $MBRX, $SYBX, $LXRX 🔥🔥🔥🔥🔥
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 5 at 4:10 AM
$SYBX Synlogic, Inc. (SYBX): Pioneering Novel Therapies to Transform Disease Care https://beyondspx.com/article/synlogic-inc-sybx-pioneering-novel-therapies-to-transform-disease-care
0 · Reply
insiderbuyingselling
insiderbuyingselling Oct. 31 at 2:18 AM
$SYBX new insider selling: 79 shares. http://insiderbuyingselling.com/?t=SYBX
0 · Reply